Citing encouraging results from a Phase 1 study in Japan, Bayer (BAYRY), Bristol-Myers Squibb (BMY) and Ono Pharmaceutical Co. (OPHLF) will collaborate on
(Bloomberg) -- Gilead Sciences Inc (NASDAQ:GILD). agreed to pay $5.1 billion to raise its stake in biotechnology company Galapagos NV to deepen its research into inflammatory...
Looking for bargains? You'll definitely want to check out these dirt-cheap healthcare stocks.
Friday, July 19, 2019The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks,...
Bristol-Myers Squibb Company (NYSE:BMY) along with Japan’s Ono Pharmaceutical and Bayer (DE:BAYGN) AG (OTC:BAYRY) has entered into a collaboration agreement to evaluate...
After stumbling into the bear market territory in the second half of last year, the U.S. biotechnology sector recovered in the first six months of this year. SPDR S&P Biotech...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Moving Averages||Strong Sell||Sell||Strong Sell||Strong Sell||Strong Sell|
|Technical Indicators||Strong Sell||Strong Sell||Strong Sell||Strong Sell||Strong Sell|
|Summary||Strong Sell||Strong Sell||Strong Sell||Strong Sell||Strong Sell|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Bullish doji Star||30||Current|
|Bullish Engulfing||1M||5||Feb 19|
|Three Inside Down||1H||6||Jul 19, 2019 09:00AM|
|Abandoned Baby Bullish||1D||8||Jul 09, 2019|
Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company's products include Empliciti, Opdivo, Sprycel, Yervoy, Eliquis, Orencia, Baraclude, Hepatitis C Franchise, Reyataz Franchise and Sustiva Franchise. It offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience, and cardiovascular. Its products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession across the world.Read More
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
|National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States)||$500||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.